Javascript must be enabled to continue!
Multi‐biomarker panel prediction model for diagnosis of pancreatic cancer
View through CrossRef
AbstractBackground/PurposeThe current study aimed to develop a prediction model using a multi‐marker panel as a diagnostic screening tool for pancreatic ductal adenocarcinoma.MethodsMulti‐center cohort of 1991 blood samples were collected from January 2011 to September 2019, of which 609 were normal, 145 were other cancer (colorectal, thyroid, and breast cancer), 314 were pancreatic benign disease, and 923 were pancreatic ductal adenocarcinoma. The automated multi‐biomarker Enzyme‐Linked Immunosorbent Assay kit was developed using three potential biomarkers: LRG1, TTR, and CA 19‐9. Using a logistic regression model on a training data set, the predicted values for pancreatic ductal adenocarcinoma were obtained, and the result was classification into one of the three risk groups: low, intermediate, and high. The five covariates used to create the model were sex, age, and three biomarkers.ResultsParticipants were categorized into four groups as normal (n = 609), other cancer (n = 145), pancreatic benign disease (n = 314), and pancreatic ductal adenocarcinoma (n = 923). The normal, other cancer, and pancreatic benign disease groups were clubbed into the non‐pancreatic ductal adenocarcinoma group (n = 1068). The positive and negative predictive value, sensitivity, and specificity were 94.12, 90.40, 93.81, and 90.86, respectively.ConclusionsThis study demonstrates a significant diagnostic performance of the multi‐marker panel in distinguishing pancreatic ductal adenocarcinoma from normal and benign pancreatic disease states, as well as patients with other cancers.
Wiley
Doo‐Ho Lee
Woongchang Yoon
Areum Lee
Youngmin Han
Yoonhyeong Byun
Jae Seung Kang
Hongbeom Kim
Wooil Kwon
Young‐Ah Suh
Yonghwan Choi
Junghyun Namkung
Sangjo Han
Sung Gon Yi
Jin Seok Heo
In Woong Han
Joon Oh Park
Joo Kyung Park
Song Cheol Kim
Eunsung Jun
Chang Moo Kang
Woo Jin Lee
Hyeon Kook Lee
Huisong Lee
Seungyeoun Lee
Seung‐Yong Jeong
Kyu Eun Lee
Wonshik Han
Taesung Park
Jin‐Young Jang
Title: Multi‐biomarker panel prediction model for diagnosis of pancreatic cancer
Description:
AbstractBackground/PurposeThe current study aimed to develop a prediction model using a multi‐marker panel as a diagnostic screening tool for pancreatic ductal adenocarcinoma.
MethodsMulti‐center cohort of 1991 blood samples were collected from January 2011 to September 2019, of which 609 were normal, 145 were other cancer (colorectal, thyroid, and breast cancer), 314 were pancreatic benign disease, and 923 were pancreatic ductal adenocarcinoma.
The automated multi‐biomarker Enzyme‐Linked Immunosorbent Assay kit was developed using three potential biomarkers: LRG1, TTR, and CA 19‐9.
Using a logistic regression model on a training data set, the predicted values for pancreatic ductal adenocarcinoma were obtained, and the result was classification into one of the three risk groups: low, intermediate, and high.
The five covariates used to create the model were sex, age, and three biomarkers.
ResultsParticipants were categorized into four groups as normal (n = 609), other cancer (n = 145), pancreatic benign disease (n = 314), and pancreatic ductal adenocarcinoma (n = 923).
The normal, other cancer, and pancreatic benign disease groups were clubbed into the non‐pancreatic ductal adenocarcinoma group (n = 1068).
The positive and negative predictive value, sensitivity, and specificity were 94.
12, 90.
40, 93.
81, and 90.
86, respectively.
ConclusionsThis study demonstrates a significant diagnostic performance of the multi‐marker panel in distinguishing pancreatic ductal adenocarcinoma from normal and benign pancreatic disease states, as well as patients with other cancers.
Related Results
Abstract 675: Performance of highly sensitive molecular biomarker for pancreatic cancer detection
Abstract 675: Performance of highly sensitive molecular biomarker for pancreatic cancer detection
Background:
Pancreatic cancer is one of the most lethal malignancies, with resection being the only potentially curative treatment. However, due to the absence of...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...
Abstract LB-80: Building Bridges for Pancreatic Cancer Research
Abstract LB-80: Building Bridges for Pancreatic Cancer Research
Abstract
Almost 40 years after President Nixon signed into law the National Cancer Act, the survival rate for pancreatic cancer has not substantially improved. Today...
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract 1695: Imaging of the interaction of pancreatic cancer and stellate cells during liver metastasis
Abstract
Pancreatic stellate cells are involved in fibrosis of pancreatic cancer. An understanding of pancreatic cancer-cell interactions with stellate cells is crit...
Abstract 438: Cholesterol biosynthesis is a critical metabolic dependency in pancreatic cancer
Abstract 438: Cholesterol biosynthesis is a critical metabolic dependency in pancreatic cancer
Abstract
Pancreatic cancer is rapidly rising to become the 2nd leading cause of cancer deaths by 2020 in the USA. The rise in pancreatic cancer incidence is parallel...
Abstract 2494: A pilot proteomic analysis to identify biomarker proteins in human pancreatic cancer using reverse phase protein array
Abstract 2494: A pilot proteomic analysis to identify biomarker proteins in human pancreatic cancer using reverse phase protein array
Abstract
Background: Pancreatic cancer is the fourth leading cause of cancer death in the U.S, and with an overall 5-year survival rate less than 4%. The high mortal...
Potential regulatory mechanisms of hsa_circ_0131457/miR-636/SFRP2 inhibition of tumor progression in pancreatic ductus adenocarcinoma
Potential regulatory mechanisms of hsa_circ_0131457/miR-636/SFRP2 inhibition of tumor progression in pancreatic ductus adenocarcinoma
Abstract
Background: Circular RNAs (circRNAs), a novel class of non-coding RNAs, have been found to act as miRNA sponges that competitively inhibit the binding of miRNA to ...
10 Fr S-Type Plastic Pancreatic Stents in Chronic Pancreatitis Are Effective for the Treatment of Pancreatic Duct Strictures and Pancreatic Stones
10 Fr S-Type Plastic Pancreatic Stents in Chronic Pancreatitis Are Effective for the Treatment of Pancreatic Duct Strictures and Pancreatic Stones
Aim. Endoscopic pancreatic stenting for refractory pancreatic duct strictures associated with impacted pancreatic stones in chronic pancreatitis cases has yielded conflicting resul...

